OMEGA ORTHODONTICS INC
NT 10-K, 1998-03-31
MANAGEMENT SERVICES
Previous: IMC HOME EQUITY LOAN TRUST 1997-1, 10-K405, 1998-03-31
Next: CVF CORP, 10KSB, 1998-03-31



                             3
               SECURITIES AND EXCHANGE COMMISSION
                     WASHINGTON D.C.  20549
                                
                           FORM 12b-25


                                        Commission File Number: 0-
                                        23055

                   NOTIFICATION OF LATE FILING

(Check One):

X    Form 10-K and Form 10-KSB    Form 11-K      Form 20-F
Form 10-Q

     For Period Ended:   December 31, 1997

Transition Report on Form 10-K               Transition Report on
Form 10-Q
Transition Report on Form 20-F               Transition Report on
Form N-SAR
Transition Report on Form 11-K

     For the Transition Period Ended:

     Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.

     If the notification relates to a portion of the filing
checked above, identify the item(s) to which the notification
relates:   NOT APPLICABLE



                             PART I
                     REGISTRANT INFORMATION

Full name of registrant:      Omega Orthodontics, Inc.

Former name if applicable:         NOT APPLICABLE

Address of principal executive office (Street and number): 3621
Silver Spur Lane

City, state and zip code:  Acton, California 93510

                             PART II
                     RULE 12b-25(b) AND (c)

     If the subject report could not be filed without
unreasonable effort or expense
 and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.  (Check box if appropriate.)

x     (a)  The reasons described in reasonable detail in Part III
           of this form could not be eliminated without
           unreasonable effort or expense;
      (b)  The subject annual report, semi-annual report,
           transition report on Form 10-K, 20-F, 11-K or Form N-
           SAR, or portion thereof will be filed on or before the
x          15th calendar day following the prescribed due date;
           or the subject quarterly report or transition report
           on Form 10-Q, or portion thereof will be filed on or
           before the fifth calendar day following the prescribed
           due date; and
      (c)  The accountant's statement or other exhibit required
           by Rule 12b-25(c) has been attached if applicable.


                            PART III
                            NARRATIVE

     State below in reasonable detail the reasons why Form 10-K,
11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof
could not be filed within the prescribed time period.

     The subject Annual Report on Form 10-KSB is the Registrant's
first Annual Report on Form 10-KSB.  Also, the Registrant
completed its initial public offering of securities on October 1,
1997 and simultaneously completed its first affiliations with
seven separate orthodontic practices.  Since that time, the
Registrant has completed affiliations with seven additional
orthodontic practices.  Accordingly, the Registrant requires
additional time to compile the financial information required to
be included in the Annual Report on Form 10-KSB and to complete
the external audit regarding the year ended December 31, 1997.

                             PART IV
                        OTHER INFORMATION

     (1)  Name and telephone number of person to contact in
          regard to this notification:  Edward M. Mulherin: (617)
          523-5717

     (2)  Have all other periodic reports required under Section
13 or 15(d) of the Securities Exchange Act of 1934 or Section 30
of the Investment Company Act of 1940 during the preceding 12
months or for such shorter period that the Registrant was
required to file such report(s) been filed?  If the answer is no,
identify report(s).

                              X Yes       No

     (3)  Is it anticipated that any significant change in
results of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements to be
included in the subject report or portion thereof?

                              X Yes       No

     If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.

     The results of operations for the year ended December 31,
1997 will differ significantly from the results of operations for
the year ended December 31, 1996.  The primary reasons for the
difference are that during the year ended December 31, 1996 the
Registrant operated for only four months, was not affiliated with
any orthodontic practices and had only limited consulting
revenues and operating expenses, while during the year ended
December 31, 1997 the Registrant operated for twelve months, was
affiliated with seven operating orthodontic practices for the
final three months of the year and generated approximately
$900,000 of net management revenues while incurring operating
expenses of approximately $5.1 million for the full year,
including a non-recurring consulting expense of approximately
$3.1 million.  Based upon the information currently available,
the earning statements to be included in the subject report are
expected to reflect an estimated net loss of approximately $4.2
million for the year ended December 31, 1997, as compared with a
net loss of $232,112 for the year ended December 31, 1996.

                    Omega Orthodontics, Inc.
          (Name of Registrant as Specified in Charter)
                                
Has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.

Date: March 31, 1998          By:  /s/ Edward M. Mulherin
                         Edward M. Mulherin, Chief Financial
Officer

       Instruction.   The  form  may  be  signed  by   an
     executive officer of the registrant or by any  other
     duly  authorized representative.  The name and title
     of  the  person signing the form shall be  typed  or
     printed beneath the signature.  If the statement  is
     signed  on behalf of the registrant by an authorized
     representative  (other than an  executive  officer),
     evidence of the representative's authority  to  sign
     on  behalf of the registrant shall be filed with the
     form.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission